Gregory Sarna

1.5k total citations
44 papers, 1.2k citations indexed

About

Gregory Sarna is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Gregory Sarna has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Hematology. Recurrent topics in Gregory Sarna's work include Hematopoietic Stem Cell Transplantation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Renal cell carcinoma treatment (3 papers). Gregory Sarna is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Renal cell carcinoma treatment (3 papers). Gregory Sarna collaborates with scholars based in United States and Sweden. Gregory Sarna's co-authors include Robert A. Figlin, Seymour Perry, Jean B. deKernion, Robert B. Smith, Arie Lindner, James E. Goodnight, Figlin Ra, Jean De Kernion, Joseph Rubin and Kay Redfield Jamison and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Gregory Sarna

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Sarna United States 18 369 268 197 188 170 44 1.2k
G. D. Ledney United States 21 231 0.6× 396 1.5× 280 1.4× 68 0.4× 301 1.8× 88 1.7k
Donald Giacherio United States 20 308 0.8× 630 2.4× 257 1.3× 107 0.6× 315 1.9× 40 1.7k
M Yamakido Japan 18 250 0.7× 809 3.0× 317 1.6× 156 0.8× 297 1.7× 117 2.3k
Celalettin Camcı Türkiye 18 297 0.8× 228 0.9× 168 0.9× 165 0.9× 49 0.3× 65 983
Hiroo Nakajima Japan 20 218 0.6× 580 2.2× 254 1.3× 171 0.9× 331 1.9× 69 1.4k
M Dąbrowska Poland 20 322 0.9× 518 1.9× 133 0.7× 180 1.0× 441 2.6× 101 1.6k
Yasuhiro Udagawa Japan 28 332 0.9× 626 2.3× 192 1.0× 342 1.8× 352 2.1× 111 2.7k
P. F. Benson United Kingdom 21 94 0.3× 564 2.1× 109 0.6× 215 1.1× 105 0.6× 86 1.6k
Jennifer Lin United States 17 363 1.0× 496 1.9× 227 1.2× 194 1.0× 94 0.6× 43 1.6k
Tadao Niijima Japan 20 207 0.6× 319 1.2× 293 1.5× 604 3.2× 87 0.5× 132 1.3k

Countries citing papers authored by Gregory Sarna

Since Specialization
Citations

This map shows the geographic impact of Gregory Sarna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Sarna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Sarna more than expected).

Fields of papers citing papers by Gregory Sarna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Sarna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Sarna. The network helps show where Gregory Sarna may publish in the future.

Co-authorship network of co-authors of Gregory Sarna

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Sarna. A scholar is included among the top collaborators of Gregory Sarna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Sarna. Gregory Sarna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silberman, Allan W., et al.. (2004). Comparative Morbidity of Axillary Lymph Node Dissection and the Sentinel Lymph Node Technique. Annals of Surgery. 240(1). 1–6. 62 indexed citations
2.
Silberman, Allan W., Gregory Sarna, & Daphne Palmer. (2000). Adjuvant Radiation Trials for High-Risk Breast Cancer Patients: Adequacy of Lymphadenectomy. Annals of Surgical Oncology. 7(5). 357–360. 4 indexed citations
3.
Sarna, Gregory, R. Hirsch, Paolo Radice, et al.. (2000). Carboplatin (C) and docetaxel (D) in previously untreated advanced non-small cell lung carcinoma (NSCLC): A multicenter phase II trial. Lung Cancer. 29(1). 61–61. 3 indexed citations
4.
Sarna, Gregory, Herbert I. Machleder, James J. Collins, et al.. (1994). A Comparative Study of Intravenous Versus Intralymphatic Interleukin-2, with Assessment of Effects of Interleukin-2 on Both Peripheral Blood and Thoracic-Duct Lymph. Journal of Immunotherapy. 15(2). 140–146. 4 indexed citations
5.
Hofmann, Bo, H Z Bass, P Nishanian, et al.. (1992). Different lymphoid cell populations produce varied levels of neopterin, β2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha. Clinical & Experimental Immunology. 88(3). 548–554. 40 indexed citations
6.
Ra, Figlin, et al.. (1988). Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.. Journal of Clinical Oncology. 6(10). 1604–1610. 52 indexed citations
7.
Sarna, Gregory, et al.. (1985). Human α-lymphoblastoid interferon. American Journal of Clinical Oncology. 8(5). 406–412. 4 indexed citations
8.
Sarna, Gregory, et al.. (1985). Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.. PubMed. 69(3). 263–7. 36 indexed citations
9.
Storm, F. Kristian, Allan W. Silberman, Larry R. Kaiser, et al.. (1984). Clinical thermochemotherapy a controlled trial in advanced cancer patients. Cancer. 53(4). 863–868. 30 indexed citations
10.
Fahey, JL, et al.. (1983). Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy.. PubMed. 2(5). 458–69. 15 indexed citations
11.
deKernion, Jean B., Gregory Sarna, Robert A. Figlin, Arie Lindner, & Robert B. Smith. (1983). The Treatment of Renal Cell Carcinoma with Human Leukocyte Alpha-Interferon. The Journal of Urology. 130(6). 1063–1066. 126 indexed citations
12.
Sarna, Gregory, Figlin Ra, & Susan McCarthy. (1983). Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.. PubMed. 2(2). 187–95. 2 indexed citations
13.
Fairbanks, Lynn A., et al.. (1982). Cannabis and cancer chemotherapy. A comparison of oral delta-9-thc and prochlorperazine. Cancer. 50(4). 636–645. 74 indexed citations
14.
Sarna, Gregory, et al.. (1981). cis-Diamminedichloroplatinum(II) alone and in combination in the treatment of testicular and other malignancies.. PubMed. 64(10-11). 1077–82. 5 indexed citations
15.
Goodnight, James E., et al.. (1980). Cis-dichlorodiammineplatinum(II) alone and combined with DTIC for treatment of disseminated malignant melanoma.. PubMed. 63(11-12). 2005–7. 23 indexed citations
16.
Feig, Stephen A., Peter Falk, Robert C. Neerhout, et al.. (1977). Experience with incompatible maternal donors for bone marrow transplantation. Annals of Hematology. 34(1). 1–9. 4 indexed citations
17.
Rp, Gale, Stephen A. Feig, Gerhard Opelz, et al.. (1976). Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARI--UCLA).. Transplantation Proceedings. 8(4). 611–6. 12 indexed citations
18.
Sarna, Gregory. (1974). The resting cell: a chemotherapeutic problem. Part I.. PubMed. 20(5). 322–6. 7 indexed citations
19.
Linde, Leonard M., et al.. (1968). Pulmonary and systemic hemodynamic effects of cardiac glycosides. American Heart Journal. 76(3). 356–364. 11 indexed citations
20.
Goldberg, Stanley J., et al.. (1968). Effects of Barbiturates on Pulmonary and Systemic Haemodynamics. Cardiovascular Research. 2(2). 136–142. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. D. Ledney Breakdown of academic impact, for papers by Donald Giacherio Breakdown of academic impact, for papers by M Yamakido Breakdown of academic impact, for papers by Celalettin Camcı Breakdown of academic impact, for papers by Hiroo Nakajima Breakdown of academic impact, for papers by M Dąbrowska Breakdown of academic impact, for papers by Yasuhiro Udagawa Breakdown of academic impact, for papers by P. F. Benson Breakdown of academic impact, for papers by Jennifer Lin Breakdown of academic impact, for papers by Tadao Niijima
Rankless by CCL
2026